Home » Prices » NASDAQ:CPRX

Catalyst Pharmaceuticals, Inc. stock price

Today's NASDAQ:CPRX chart, history & news

Price:
3.70 USD
Change:
+0.21 (6.02%)
Key Stats
Price open 3.53
Previous close 3.49
Market cap 383.50M
Volume 1.17M
Day high 3.72
Day low 3.513
Year high 5.21
Year low 2.61
Year to date change 4.16%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Company information

Company name
Catalyst Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Other
Employees
76
CEO
Patrick J. McEnany
Address
355 Alhambra Circle, Coral Gables, FL, 33134
Country
United States
Contact information
1.305.420.3200
Website
http://www.catalystpharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.